Wooohooo!
In light of the positive data received from the Timpson Laboratory and the emerging clinical data from the Company’s Phase 1 trial in healthy volunteers, Amplia has now started planning a Phase 2 clinical trial of AMP945 in pancreatic cancer patients. Amplia is currently working closely with a range of clinical advisors, clinical pharmacologists, statisticians and potential vendors to finalise the required regulatory applications and refine the study protocol.
Ann: Preclinical Data Support Developmnt AMP945 Pancreatic Cancer, page-2
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.21M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.5¢ | 14.5¢ | $83.61K | 528.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 68334 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 60177 | 1 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| ATX (ASX) Chart |